GRISACTIN ULTRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Grisactin Ultra, and what generic alternatives are available?
Grisactin Ultra is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in GRISACTIN ULTRA is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
Summary for GRISACTIN ULTRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 4,504 |
DailyMed Link: | GRISACTIN ULTRA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GRISACTIN ULTRA
US Patents and Regulatory Information for GRISACTIN ULTRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062178-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062438-002 | Nov 17, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062438-001 | Nov 17, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062178-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |